Culturally adapted SHARE program for African-American families coping with early to moderate dementia

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Researchers will work with an advisory committee of African American people with lived experience and experts to tailor SHARE counseling materials and create counselor and family guides. They will run focus groups with African American caregiver–care-recipient dyads and community service providers to refine the materials and procedures. After training 20 SHARE counselors on the adapted version, the team will conduct a randomized controlled trial enrolling 120 African American dyads to compare the adapted SHARE program with usual care. Outcomes will include feasibility, acceptability, and preliminary effects on care planning and caregiver well-being.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* African American dyads (both the caregivers and the care-recipient, an individual with an early-stage memory impairing condition (e.g., Alzheimer's disease, vascular dementia, cognitive impairment, etc.)
* Care-recipient lives at home.
* The caregiver (CG) and/or the person with dementia (PWD), or symptoms of memory loss must identify as African American.
* PWD must be at least 50 years old and CGs 18 or older,
* Ability to speak and read English,
* Experiencing signs and symptoms of mild to moderate dementia through family caregiver report on the Dementia Severity Rating Scale and meeting the National Institute on Aging and the Alzheimer's Association clinical criteria for probable AD.

Exclusion Criteria:

* A mental health condition (e.g., schizophrenia, bipolar disorder, major depression)
* A traumatic brain injury
* Intellectual or developmental disability
* Individuals experiencing extreme difficulty adjusting and coping to the diagnosis • Individuals living in an institutional setting

Where it's running

• Benjamin Rose
  Cleveland, Ohio, United States Recruiting

Study contacts

• Principal investigator: Silvia Orsulic-Jeras — Benjamin Rose Institute on Aging
• Study coordinator: Silvia Orsulic-Jeras
• Email: sjeras@benrose.org
• Phone: 2163731625

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Non-invasive brain stimulation to try to improve memory in early Alzheimer's

  Scientists test whether repetitive transcranial magnetic stimulation to the cerebellum can help short-term memory in people with early Alzheimer's disease compared with a sham procedure.

  Recruiting Baylor College of Medicine · Houston, Texas · NCT07667478

• Dementia-friendly pharmacies as a mental health resource for older adults

  This project tests whether pharmacies with memory-test stations can find early cognitive problems in people 60 and older and connect them to follow-up care and support.

  Recruiting Ludwig-Maximilians - University of Munich · Munich, Bavaria · NCT07504965

• Fitbit-supported walking program with care partner coaching, text reminders, videos, and virtual physical therapy for older adults with mild dementia

  This program will try a Fitbit-based approach with text reminders, instructional videos, and virtual physical therapy alongside a care partner to see if it helps older adults with mild dementia walk more and stay active.

  Recruiting NYU Langone Health · New York, New York · NCT07321587

• Aromatherapy for Mild Cognitive Impairment and Mild Dementia

  This study tests whether a diffused essential-oil blend for 6 months can help reduce symptoms for people with MCI or mild dementia and lessen caregiver stress.

  Recruiting at 2 sites National Cancer Centre, Singapore · Singapore and 1 other locations · NCT07234357

• KDS2010 for people with MCI or mild dementia due to Alzheimer's disease.

  This trial will test whether taking KDS2010 once daily for 24 weeks helps thinking and memory and is safe in people aged 50–85 who are amyloid-positive with MCI or mild Alzheimer's dementia.

  Recruiting at 8 sites Phase 2 NeuroBiogen Co., Ltd · Gwangju, Gwangju and 7 other locations · NCT07027072

• Investigating new blood tests for diagnosing memory disorders

  This study is testing new blood tests to see if they can help diagnose memory disorders like mild dementia and Alzheimer's better than the current method that uses spinal fluid.

  Recruiting Skane University Hospital · Malmö · NCT06122415

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.